Basket cover image
17 handpicked stocks

America's New Transcontinental Railroad

Union Pacific's acquisition of Norfolk Southern for $85 billion creates the first coast-to-coast railroad in the U.S. This theme focuses on companies poised to benefit from the resulting improvements in supply chain efficiency and logistics.

stock
stock
stock
stock
stock
stock
stock
stock
stock
stock

+7

Author avatar

Han Tan | Market Analyst

Updated 3 days ago | Published at juillet 30

Top Picks from This Group

Here are a few of the assets in this group. Create an account to unlock the full list.

UNP

Union Pacific Corporation

UNP

Current price

$223.77

NSC

Norfolk Southern Corporation

NSC

Current price

$285.53

CSX

CSX Corp.

CSX

Current price

$36.52

About This Group of Stocks

1

Our Expert Thinking

The $85 billion Union Pacific-Norfolk Southern merger creates America's first single-owner transcontinental railroad network. This historic consolidation has the potential to revolutionize national logistics by streamlining freight movement from coast to coast, creating significant opportunities for companies throughout the supply chain ecosystem.

2

What You Need to Know

This group includes the primary railroad operators involved in the consolidation, their key competitors, and logistics companies that rely heavily on rail transport. These businesses may benefit from reduced transit times, lower shipping costs, and enhanced network reliability as the new unified system takes shape.

3

Why These Stocks

These companies were handpicked by professional analysts as direct and indirect beneficiaries of this landmark railroad merger. From intermodal transport providers to trucking firms, each stock represents exposure to the potential long-term impact of America's new transcontinental rail network.

12 Month Growth Potential

Use the growth calculator to see how much investing in these assets could return over one year.

If you invested across these assets:

in 12 months it could be worth:

$1,000.00

+26.63%

Group Performance Snapshot

26.63%

Average 12 Month Profit

On average, analysts expect assets in this group to grow 26.63% over the next year.

11 of 17

Stocks Rated Buy by Analysts

11 of 17 assets in this group are rated Buy by professional analysts.

Source: Analyst sentiment is provided by Refinitiv Ltd, a global leader in financial market data with over 40k business clients. Refinitiv Ltd is an independent third party to Nemo. This is not advice.

Why You'll Want to Watch These Stocks

🚂

Historic Infrastructure Play

This is the first time in U.S. history that a single company will own a true coast-to-coast railroad network. You're looking at a once-in-a-generation infrastructure transformation that could reshape American commerce.

Supply Chain Revolution

A unified transcontinental rail system means faster, cheaper, and more reliable freight movement. Companies that depend on shipping goods across the country could see their costs drop and efficiency soar.

💎

Expert-Selected Winners

These aren't random logistics stocks. Professional analysts handpicked each company based on their potential to benefit from this $85 billion mega-merger and the new opportunities it creates.

Why Invest with Nemo Money?

Nemo Logo Fade
🆓

Zero Commission

Trade stocks, ETFs, and more with zero commission. Keep more of your returns.

🔒

Trusted & Regulated

Part of Exinity Group 2015, serving over a million customers globally.

💰

6% Interest on Cash

Earn 6% AER on uninvested cash with daily interest payments.

Discover More Opportunities

The New Cost of Compliance: Investing in HR Tech

The New Cost of Compliance: Investing in HR Tech

Australian airline Qantas received a historic $58 million fine for unlawfully dismissing workers, setting a new precedent for corporate accountability in labor practices. This ruling creates an investment opportunity in companies that provide the essential HR, legal, and compliance technologies businesses now need to navigate stricter labor law enforcement.

View stocks
GLP-1s Target Liver Disease

GLP-1s Target Liver Disease

The FDA's approval of Wegovy for a serious liver disease has boosted Novo Nordisk's market position and highlighted a major new application for GLP-1 drugs. This development creates an investment opportunity in companies focused on innovative treatments for metabolic and liver-related conditions.

View stocks
Pharma's Digital Prescription

Pharma's Digital Prescription

Novo Nordisk is partnering with GoodRx to offer its popular drug Ozempic at a reduced price, boosting GoodRx's stock. This collaboration highlights a growing trend of pharmaceutical companies leveraging digital health platforms to improve drug affordability and expand market reach.

View stocks
View All Stock Groups

Frequently Asked Questions

Everything you need to know about the product and billing.